Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,109 | 102,174 | 73,506 | 9,774 | 12,867 |
| Marketable Securities | 148,467 | 136,380 | 39,977 | 54,384 | 59,587 |
| Receivables | N/A | 5,692 | 8,797 | 8,281 | 8,725 |
| Inventories | N/A | N/A | 3,523 | 3,570 | 2,260 |
| Other current assets | 3,058 | 0 | 1,835 | 2,107 | 0 |
| TOTAL | $281,688 | $277,019 | $130,975 | $82,380 | $88,602 |
| Non-Current Assets | |||||
| PPE Net | 373 | 407 | 472 | 544 | 770 |
| Intangibles | 16,836 | 16,836 | 19,101 | 19,304 | 19,510 |
| Other Non-Current Assets | 28,738 | 47,139 | 57,177 | 49,208 | 47,006 |
| TOTAL | $45,947 | $64,382 | $76,750 | $69,056 | $67,286 |
| Total Assets | $327,635 | $341,401 | $207,725 | $151,436 | $155,888 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,914 | 5,855 | N/A | 35 |
| Accounts payable and accrued liabilities | 2,660 | 4,879 | 6,790 | 6,100 | 3,538 |
| Accrued Expenses | 16,398 | 15,820 | 14,858 | 19,810 | 17,017 |
| Other current liabilities | 3,431 | 3,488 | 1,932 | 9,429 | 9,577 |
| TOTAL | $23,009 | $27,018 | $32,336 | $35,984 | $31,763 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,520 | 124,879 | 123,258 | 121,686 | 120,132 |
| Other Non-Current Liabilities | 6,906 | 7,379 | 20,064 | 22,965 | 30,956 |
| TOTAL | $133,426 | $132,258 | $143,322 | $144,651 | $151,088 |
| Total Liabilities | $156,435 | $159,276 | $175,658 | $180,635 | $182,851 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,273 | 58,221 | 58,129 | N/A | N/A |
| Common Shares | 582 | 635 | 518 | 429 | 428 |
| Retained earnings | -372,909 | -361,206 | -392,080 | -391,215 | -388,476 |
| Other shareholders' equity | -21,918 | -22,516 | -23,625 | -22,804 | -22,970 |
| TOTAL | $171,200 | $182,125 | $32,067 | $-29,199 | $-26,963 |
| Total Liabilities And Equity | $327,635 | $341,401 | $207,725 | $151,436 | $155,888 |